Your session is about to expire
← Back to Search
Anesthetic
Spinal anesthesia group for Dementia
N/A
Waitlist Available
Led By George Djaiani, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions
No Placebo-Only Group
Summary
This trialinvestigates if elderly patients are less likely to develop dementia/Alzheimers if they have spinal (awake/sedated) vs. inhalational (asleep) anesthesia for surgery, taking into account risk factors.
Eligible Conditions
- Dementia
- Alzheimer's Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Spinal anesthesia groupActive Control4 Interventions
Spinal anesthesia group will receive bupivacaine 10-15mg anesthesia according to the standard practice. Supplemental sedation with intravenous anesthetics (midazolam/propofol) will be optional.
Group II: General anesthesia groupActive Control4 Interventions
Induction of anesthesia will be achieved with propofol 1.5-2mg/kg and fentanyl 1-3g/kg. Anesthesia will be maintained with inhalational anesthesia (isoflurane or sevoflurane) at the discretion of anesthesiologist in charge of the case. A mixture of Air/O2 will be used to maintain adequate oxygenation. Nitrous oxide will not be used.
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,523 Previous Clinical Trials
502,838 Total Patients Enrolled
16 Trials studying Dementia
1,548 Patients Enrolled for Dementia
George Djaiani, MDPrincipal InvestigatorToronto General Hospital, University Health Network
4 Previous Clinical Trials
1,716 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger